RE: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

E Arbustini, A Sgarella, A Ferrari… - JNCI: Journal of the …, 2016 - academic.oup.com
The recently reported association of K3326X variant with the risk of developing breast and
ovarian cancers independently of other pathogenic variants in BRCA2 (1) presents three …
被引用次数：10 相关文章

[引用][C] RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

E Arbustini, A Sgarella, A Ferrari, D Grasso… - Journal of the National …, 2016 - cir.nii.ac.jp
RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian
Cancers | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ移動 検索 …

[引用][C] RE: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

E Arbustini, A Sgarella, A Ferrari, D Grasso… - JOURNAL OF THE …, 2016 - iris.unipv.it
RE: BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian
cancers IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …

RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers

E Arbustini, A Sgarella, A Ferrari… - Journal of the …, 2016 - pubmed.ncbi.nlm.nih.gov
RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian
Cancers RE: BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and …